18:45 - 20:15
Carrasco Hall

Understanding NASH as a metabolic disease

Evening Session

Kenneth Cusi (USA)
Welcome and introduction
Filip Knop (Denmark)
The global burden of NASH
Michael Roden (Germany)
Connecting NASH with its metabolic risk factors: understanding the pathophysiology
Rohit Loomba (USA)
NASH in the clinic: overcoming barriers to diagnosis for patients at risk
Kenneth Cusi (USA)
Managing NASH by targeting metabolic risk: current and emerging strategies
Kenneth Cusi (USA), Michael Roden (Germany), Rohit Loomba (USA)
Panel discussion and meeting close
Symposium by: